Tzu-chen C. Yen
Chang Gung Memorial Hospital Linkou Branch, 333
Taoyuan, TNQ, Taiwan
Taoyuan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 309 publications
[18F]-florzolotau PET imaging in Alzheimer's disease: Current evidence and future directions.
Journal: Journal of Alzheimer's disease : JAD
Published: July 28, 2026
Clinical Knowledge-Guided PET/CT Lesion Segmentation With Interpretable Fusion of Metabolic and Structural Cues.
Journal: IEEE transactions on medical imaging
Published: April 23, 2026
Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 11, 2026
White matter 18F-florbetapir retention predicts cognitive decline and treatment response in Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: March 04, 2026
Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.
Journal: Brain : a journal of neurology
Published: January 26, 2026
Serum Metabolomics for Prognostic Stratification in Resected Advanced-Stage Oral Cavity Cancer.
Journal: JAMA otolaryngology-- head & neck surgery
Published: December 04, 2025
Surgery alone achieves comparable survival to adjuvant therapy in T4aN0M0 gingival squamous cell carcinoma with clear surgical margins: A registry-based propensity-matched analysis.
Journal: Oral oncology
Published: October 29, 2025
Plasma p-Tau217 improves diagnostic accuracy and clinician confidence in cognitive disorder classification.
Journal: Innovation (Cambridge (Mass.))
Published: October 10, 2025
Utility of 18F-Florzolotau PET as a prognostic and monitoring biomarker in a memory clinic cohort.
Journal: Alzheimer's research & therapy
Published: September 15, 2025
18F-FDG, 18F-FP-CIT, and 18F-Florzolotau PET Imaging in Progressive Supranuclear Palsy: Region-Specific Correlations Between Glucose Metabolism, Dopaminergic Function, and Tau Pathology.
Journal: Clinical nuclear medicine
Published: August 05, 2025
Comparative [18F]Florzolotau and [18F]FDG PET Imaging Patterns in Anti-IgLON5 Disease and Progressive Supranuclear Palsy.
Journal: Clinical nuclear medicine
Published: July 03, 2025
Self-Reported REM Sleep Behavior Disorder in Patients With Progressive Supranuclear Palsy: Clinical and 18F-Florzolotau PET Imaging Findings.
Journal: Neurology
Published: February 14, 2025
Last Updated: 09/26/2026